2024
Can Contrast Injections Cause or Propagate Coronary Injuries? Insights From Vessel and Guiding Catheter Hemodynamics
Chamié D, Bahl R, Maia J, Echavarria-Pinto M, Gafore S, Saleh A, Cristea E, Seligman H, Joaquim R, Feres F, Sen S, Al-Lamee R, Centemero M, Baker C, Johnson T, Shun-Shin M, Lansky A, Petraco R. Can Contrast Injections Cause or Propagate Coronary Injuries? Insights From Vessel and Guiding Catheter Hemodynamics. Journal Of The Society For Cardiovascular Angiography & Interventions 2024, 102396. DOI: 10.1016/j.jscai.2024.102396.Peer-Reviewed Original Research
2019
Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System 12-Month Results From the TOBA II Study
Gray WA, Cardenas JA, Brodmann M, Werner M, Bernardo NI, George JC, Lansky A. Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System 12-Month Results From the TOBA II Study. JACC Cardiovascular Interventions 2019, 12: 2375-2384. PMID: 31806218, DOI: 10.1016/j.jcin.2019.08.005.Peer-Reviewed Original ResearchMeSH KeywordsAgedAngioplasty, BalloonBlood Vessel ProsthesisBlood Vessel Prosthesis ImplantationEuropeFemaleFemoral ArteryHumansMaleMiddle AgedPeripheral Arterial DiseasePopliteal ArteryProspective StudiesProsthesis DesignRisk FactorsStentsTime FactorsTreatment OutcomeUnited StatesVascular Access DevicesVascular PatencyVascular System InjuriesConceptsProximal popliteal arteryDrug-coated balloonsSuperficial femoral arteryPlain balloonPopliteal arteryFemoral arteryTack Endovascular SystemLong-term outcomesDCB angioplastyEfficacy endpointPrimary patencyResidual stenosisRestenotic lesionsMulticenter studyFemoropopliteal arteriesEndovascular SystemAngioplastyArteryClassification 2DissectionLesionsBalloonStenosisPatencyPatients
2002
Fate of nonflow-limiting dissections after treatment with iridium-192 therapy: results from the GAMMA I and II trials
Shirai K, Lansky A, Costantini-Ortiz C, Corral M, Dave N, Dieter L, Berger P, Desai K, Leon M. Fate of nonflow-limiting dissections after treatment with iridium-192 therapy: results from the GAMMA I and II trials. Journal Of The American College Of Cardiology 2002, 39: 14. DOI: 10.1016/s0735-1097(02)80056-0.Peer-Reviewed Original Research